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Summary 
In this study, the insulin mimetic activity of ammonium decavanadate (DV) (in 
concentration 0.1 and 1.0 mM) dissolved in saline (0.9 % w/v of NaCl) or dimethyl 
sulfoxide, DMSO (2% v/v) was evaluated by means of in vitro measurements of the 
glucose uptake (GU) and inhibition of free fatty acids release (IFFAR) using isolated 
epinephrine-pretreated white adipocytes from Wistar rats.  
 Our data showed strong insulin mimetic effect of DV (> 80 %) in both 
concentration and independently of the solvent were used.     
 Having in mind satisfactory pharmacological effect of DMSO as well as its 
capability of penetration enhancer it would be reasonable to continue in vivo testing of 
dose-dependent insulin mimetic effect of decavanadate in DMSO. It is also necessary to 
examine toxicity of decavanadate in order to estimate its therapeutic index as potential 
antidiabetic agent.  
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Introduction  
Diabetes mellitus (DM) is the most common endocrine disease. The 
disease is characterized by metabolic abnormalities and by long-term 
complications involving the eyes, kidneys, nerves, and blood vessels. It is 
associated with reduced life expectancy, significant morbidity due to specific 
diabetes related acute and chronic complications. 
In recent years, it is a growing interest in examining of potential insulin 
mimetic metallopharmaceuticals based on characteristic properties of the metal 
ions. 
Studies of biomedical activity of inorganic compounds like molybdenum, 
tungstate and vanadium have attracted the attention of numerous investigators 
[1-4].  
It has been shown that in millimolar concentration range the oligoanions 
of V (V), W (VI) and Mo (VI) are potent inhibitors of muscle glycogen 
phosphorylases and compete with glucose-1-phosphate binding [5]. Vanadate 
mimics virtually all the biological effects of insulin in a large variety of insulin–
dependent tissues [6]. In the study of Nomiya et al. [7] it was shown that 
streptozotocin (STZ)–induced diabetes mice treated with decavanadate 
exhibited significant decrease in blood glucose level and decrease of body 
weight. Among the other insulin mimetic effects on isolated rat adipocytes, 
vanadate exhibits increasing glucose uptake and inhibition of lipolysis [8]. 
  
The aim of this study was to investigate the dose-dependent effect and 
influence of dissolving agents on insulin-mimetic activity of ammonium 
decavanadate [(NH4)6V10O28 • 6H2O), DV]. Two different concentrations (0.1 
mM and 1.0 mM) of DV were tested. Influence of solvents on biological 
activity we investigated using aqueous, isotonic, saline solution (S), and 2 % 
dimethyl sulfoxide (DMSO). DMSO has the unique capability to penetrate 
living tissues without damage and this agent is a commonly utilised carrier of 
chemical compounds that facilitates their incorporation into the cells or tissues. 
DMSO possesses the antioxidant activity [9] and positive effect in alloxan-
induced diabetes in mice [10].  
Materials and methods 
Insulin-mimetic activity of decavanadate in terms of inhibition of free 
fatty acids release (IFFAR) and glucose uptake (GU) was tested according the 
Sakurai et al. [11] and Rodbell [12] in vitro experimental model using isolated 
rat adipocytes pretreated with epinephrine. It could be proposed that the 
investigated compound has an insulin mimetic activity in vitro, if it shows the 
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same effect as insulin when added to the adipocytes which were pretreated with 
insulin antagonist.  
Chemicals 
Ammonium decavanadate, (NH4)6V10O28 · H2O (V) was synthesized 
starting from ammonium metavanadate, NH4VO3 (Merck), following the 
procedure recently reported by Todorovic et al.[13]. The contents of vanadium  
in the obtained compounds were checked by inductively coupled plasma atomic 
spectroscopy method (ICP-AES), and no differences were detected in the 
obtained and the theoretical values. 
Animals 
Male Wistar rats (six weeks old, weighing 150-180 g) were provided 
from the Military Medical Academy Animal House, Belgrade. The animals 
were maintained with commercial rat feed and water available ad libitum. They 
were housed in polypropylene cages (each group contained ten rats) with a wire 
mesh top and a hygienic bed of soft wood scrapings with proper humane care. 
Temperature and humidity were maintained at 25±2°C and 55±15 %, 
respectively. Animal studies were conducted in accordance with the 
institutional guidelines for care and use of laboratory animals.  
Preparation of Adipocytes 
Rats were sacrificed under ether anesthesia, and the epididymal white 
adipose tissues were removed and rinsed in isotonic salt solution (0.9 % w/v of 
NaCl). Up to 1 g of adipose tissue was digested with 10 mg of collagenase Type 
II (Sigma)  in 3 mL, 1 h at 37 C in Krebs-Ringer bicarbonate (KRB) buffer 
(120 mM NaCl, 1.27 mM CaCl2, 120 mM MgSO4, 4.75 mM KCl, 1.20 mM 
KH2PO4, 24.0 mM NaHCO3, 2% albumin, pH 7.4). Adipocytes were liberated 
from the tissue fragments by stirring with a rod, which was manifested by an 
increased turbidity in the medium. Fragments of tissues still remaining after this 
treatment were removed with forceps. The suspension of cells was centrifuged 
for 1 min at 400 x g. The fat cells floated to the surface, and the stromal-
vascular cells were sedimented. Stromal-vascular cells were completely 
removed from the fat cell preparation after three washes. Fat droplets floated 
more rapidly to the surface than the fat cells and were aspirated from the 
surface, after gently stirring the cell suspension. The adipocytes were obtained 
from the pooled adipose tissue of three rats. The washed cells (2  106 cells/mL) 
were suspended in KRB buffer with 5 mM glucose, 0.1 mM/1 mM of 
decavanadate dissolved in isotonic salt solution (saline) (0.9 % w/v of NaCl) or 
dimethyl sulfoxide (2 % v/v). Control cells were suspended in KRB buffer with 
insulin (1 U/mL). Cells were pre-incubated at 37C for 30 min. After 
preincubation 10-5M epinephrine dissolved in saline was added, and the cells 
were incubated at 37C for 3 h in CO2 incubator (MMM, Einrichtungen GmbH). 
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The reaction was stopped by cooling with ice-water. The final 
concentrations were as follows: glucose 5 mM, decavanadate 0.1mM /1.0 mM, 
epinephrine 10-5 M and saline (0.9 %, v/v)/DMSO (2 %, v/v). The extracellular 
concentration of free fatty acids was determined by a sensitive colorimetric 
micro method [14]. The concentration of extracellular glucose was obtained by 
the GOD/PAP method [15]. All tests were run in triplicate.  
The amount of glucose taken up by adipocytes was calculated from the 
decrease of glucose in the extracellular medium and inhibition of free fatty 
acids release was calculated from the decrease of free fatty acids in the 
extracellular medium, too. The glucose uptake (%) and inhibition of free fatty 
acids release (%) ability of the decavanadate was calculated according to the 
cells treated with epinephrine: Glucose uptake (%) = 100 – [(cDV / cepinepfrine)  
100], cDV and cepinepfrine  were the concentration of glucose in the extracellular 
medium after incubation with DV and epinephrine,  respectively. Inhibition of 
free fatty acid release (%) = 100 – [(cDV / cepinephrine)  100], cDV  and cepinepfrine 
were the concentration of free fatty acids in the extracellular medium after 
incubation with decavanadate and epinephrine, respectively. 
For the easier interpretation of obtained results we calculated the percent 
of insulin-mimetic effect on isolated adipocytes as the mean values of the both 
effects, glucose uptake and the inhibition of free fatty acids release: 
Insulin-mimetic effect (%) = [Glucose uptake (%) + Inhibition of free 
fatty acids release (%)] / 2 
Statistics 
Descriptive statistics was used for the level of glucose and  the level of 
free fatty acids in treated groups and data were shown as mean ± standard error 
of mean (S.E.M).  
Analysis of variance was used to compare insulin-mimetic effect between 
the treated groups. Post hoc comparisons were determined by the least 
significant difference (LSD) if the F-value for the parameters was significant. 
For statistical analysis, SPSS for Windows 10 was applied and the P < 0.05 was 
considered to be significant. 
Results 
In order to compare the insulin mimetic activity of the decavanadate 
according the concentration and solvent we compared inhibition of free fatty 
acids release and glucose uptake by isolated rat adipocytes treated with 
epinephrine. Glucose and free fatty acids levels in the extracellular medium of 
adipocytes treated with DV as well as with insulin were significantly lower than 
in epinephrine treated cells (Figure 1. a, b).  
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Figure 1.  Effect of ammonium decavanadate (DV) in two different  
 concentrations (0.1 mM, 1.0 mM) and with two different  
 dissolving agents (S-saline, D-DMSO) on concentration of:  
 a) glucose, in the extracellular medium  
 b) free fatty acids in the extracellular medium from isolated rat  
 adipocytes treated with epinephrine in the presence of 5 mM  
 glucose. Each column represents the means ± S.E.M. Blank (B),  
 epinephrine (E) and insulin (I) are adipocytes without any  
 hormone or compound, treated with epinephrine and with  
 insulin, respectively. The insulin- or decavanadate-treated  
 adipocytes compared with epinephrine-treated adipocytes and  








































Figure 2. shows mean values of the insulin-mimetic effect of DV in two  
different concentrations (0.1 mM, 1.0 mM) and in two different solvents (saline 
or DMSO). The biological effect was compared by the post hoc test between 
groups of treated adipocytes.  
 
Figure 2.  Insulin-mimetic effect (%) of ammonium decavanadate in two  
 different concentrations (0.1 mM, 1.0 mM) and dissolved in  
 DMSO (D) or in saline (S). Data represent the mean ± S.E.M.  
 
In the Table I post hoc comparison of insulin mimetic effect between all 
investigated groups was presented. No differences were detected between 
investigated groups of treated adipocytes. 
 
Table I  Comparisons of the insulin mimetic effect (%) between investigated  











V-0.1-D / 0.580 0.691 0.393 
V-0.1-S 0.580 / 0.922 0.763 
V-1.0-D 0.691 0.922 / 0.713 






















In this study we investigated insulin mimetic effect of DV on rat 
adipocytes pretreated with epinephrine. Epinephrine is insulin antagonist. 
Physiologically, it elevates the blood glucose level by increasing catabolism of 
glycogen to glucose in the liver, and at the same time begins the breakdown of 
lipids in fat cells. Epinephrine's actions are mediated through adrenergic 
receptors. When epinephrine binds to the -receptor of adipocytes it elevates 
concentration of cyclic adenosine 3`, 5`-monophosphate (cAMP) by activation 
of adenylate cyclase. Increase of cAMP subsequently activates some protein 
kinases. In adipocytes, hormone sensitive lipases are activated to hydrolyze 
triglycerides to glycerol and free fatty acids. In the group of adipocytes treated 
only with epinephrine we found elevated glucose level and free fatty acids in 
extracellular matrix comparing to the untreated adipocytes (Figure 1. a, b). The 
opposite results were obtained after adding of insulin in epinephrine-pretreated 
adipocytes. The insulin is the hormone which binds to the insulin receptor and 
catalyzes the auto-phosphorylation which in turn stimulates the tyrosine kinase 
which phosphorylates insulin receptor substrate. The signal information is 
converted to downstream locations such as phosphatidyl inositol-3 kinase, and 
the glucose transporter-4 which then translocates to the cell membrane. 
Consequently, glucose uptake by adipocytes is facilitated and releasing of free 
fatty acids from adipocytes is inhibited, resulting in decreasing of extracellular 
levels of both glucose and free fatty acids (Figure 1. a, b).  
In addition, we investigated the insulin mimetic effect of decavanadate 
and influence of concentrations and solvents on that bioeffect. Our results 
showed that decavanadate exhibited high insulin mimetic effect on isolated rat 
adipocytes. The decavanadate treatment of adipocytes resulted in decreasing of 
extracellular glucose and free fatty acids levels, which could be explained by 
facilitated glucose uptake by adipocytes and suppression of lipolysis, 
respectively, similarly to effect under the insulin treatment. This model is the 
simple method for evaluating, the in vitro insulin mimetic activity of certain 
compound.  
Generally, ammonium decavanadate exhibited insulin mimetic activity in 
investigated concentrations (0.1 mM and 1.0 mM ) and dissolved in both 
solvents (saline or DMSO). No differences of insulin mimetic effect of DV, 
expressed in percent (Figure 2 a,b), were detected between adipocytes treated 
with different concentration of the compound dissolved in saline or DMSO 
(Table 1).  
Although, insulin mimetic effect of decavanadate in vivo has been proved 
[7], in vitro investigations are scarce. García-Vicente et al. [16] reported that 
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sodium decavanadate salt in concentrations ranging from 5 to 50 µM did not 
stimulate glucose transport into adipose cells in vitro.  
Our data showed that double higher concentration of decavanadate (0.1 
mM = 100 µM) than in their study (50 µM) facilitated glucose uptake by 
adipocytes. On the basis of our preliminary results should be further 
investigated narrower range of concentration of decavanadate (between 0.1 mM 
and 1.0 mM) on insulin mimetic effect. 
More attention was directed to other vanadium compounds as insulin 
mimetics. Therefore, Adachi et al. [17] reported high in vitro insulin-mimetic 
activity of bis(picolinato)vanadyl and bis(6-methylpicolinato) vanadyl 
complexes, by both uptake of glucose and inhibition of FFA release, in the 
adipocytes pretreated with epinephrine.  
Li et al. [18] showed that vanadate is effective insulin mimetic due its 
ability to inhibit adipose phosphotyrosine phosphatases (negative regulator of 
insulin-mediated signal transduction). The same study showed that antilipolysis 
of vanadate can be manifested via alternative, insulin-independent, signal 
transduction pathways. Inhibition of phosphotyrosine phosphatases by organo-
vanadium compound - bis(maltolato)oxovanadium was proved by recent in vitro 
and in vivo studies [19-21].  
In the present study we also tested usefulness of DMSO as the well-
known carrier of compounds across the cell membrane. It is well known that 
DMSO is a good polar aprotic solvent that dissolves both polar and nonpolar 
compounds. Also, it has been documented that DMSO readily crosses most 
tissue membranes of lower animals and man [22]. 
Although the study of Wieser at al. [23] showed that DMSO stimulates 
cAMP accumulation and lipolysis and decrease insulin-stimulated glucose 
oxidation in free white fat cells of the rat, our data showed that 2 % DMSO as 
the solvent had no such diabetic effect. Moreover, our data showed high 
antidiabetic effect of decavanadate dissolved in 2 % DMSO. In this study, we 
not investigated the insulin mimetic effect of DMSO as the agent on adipocytes. 
Therefore, we can assume that used concentration of DMSO (2%) was too low 
for diabetic effect or DMSO facilitated transport of decavanadate in adipocytes 
so that the overall effect was antidiabetic.  
Pharmacological properties of DMSO have been well documented 
[reviewed in 24]. Even the Layman et al. study [25] showed that oral 
application of 2 % DMSO reduced development of dietary cholesterol-induced 
atherosclerosis in rabbits and suppressed the accumulation of cholesterol in 
tissues and suggested that its antiatherogenic effect was related to its capacity to 
reduce the binding, uptake, and degradation of plasma low density lipoprotein. 
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Having in mind that atherosclerosis is chronic complication of diabetes mellitus 
it is clear that this antiatherogenic agent could be useful in delivering of 
antidiabetics.  
In addition to a number of biological effects which shows decavanadate 
[26] it is necessary to examine its toxicity in order to safely use its beneficial 
effects. 
In conclusion, on the basis of this in vitro experimental study it would be 
reasonable to continue in vivo testing of dose-depending insulin mimetic effect 
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Ispitana je insulin mimetička aktivnost amonijum dekavanadata (DV), in vitro 
merenjem preuzimanja glukoze (GU) i merenjem inhibicije oslobađanja slobodnih 
masnih kiselina (IFFAR) na modelu izolovanih belih adipocita Wistar pacova. 
 Ovaj biološki efekat dekavanadata (u koncentracijama od 0,1 i 1,0 mM) koji je 
rastvoren u fiziološkom rastvoru (0.9 % NaCl) ili u dimetil sulfoksidu (2% DMSO) 
ispitan je na adipocitima koji su prethodno tretirani adrenalinom. 
 Prema dobijenim rezultatima dekavanadat pokazuje snažan insulin mimetički 
efekat (> 80 %) i to u obe koncentracije i nezavisno od vrste rastvarača.  
 Na osnovu ovog in vitro eksperimenta može se zaključiti da bi bilo opravdano 
dozno-zavisno ispitivanje insulin mimetičkog efekta dekavanadata u DMSO-u kao 
rastvaraču u in vivo uslovima. Takođe, neophodno je ispitati i toksičnost ovog jedinjenja 
kako bi se što bezbednije iskoristio njegov insulin mimetički efekat.   
 
Ključne reči: dekavanadat; dimetilsulfoksid; insulin mimetik  
 
 
 
